Aisthesis Medical

🚨 Big news for Aisthesis Medical! 🚨 We’re thrilled to announce that Aisthesis Medical has been awarded the City St George’s, University of London SME Innovation Voucher Award to conduct a retrospective external clinical validation study of #VIOSync, in collaboration with St George's University Hospitals NHS Foundation Trust! This award allows us to further validate #VIOSync Sepsis Prediction Index, ensuring its accuracy, reliability, and real-world clinical impact. Why does this matter? ➡ Sepsis kills 11 million people annually ➡ Every hour of delay increases mortality risk by 8% ➡ Early detection can save lives and reduce healthcare costs By leveraging real-time patient data and predictive AI, #VIOSync empowers clinicians to intervene earlier—potentially improving patient outcomes by 30% and saving hospitals millions in preventable costs. A huge thank you to our clinical collaborators Prof. Andrew Rhodes, Dr Dagan Lonsdale, and Dr. Rhodri Handslip for joining us on this journey. Their expertise and support in this mission will be instrumental in validating VIOSync’s impact in real-world settings. This is just the beginning – stay tuned as we continue to push the boundaries of AI in healthcare. #ClinicalAI #Sepsis #SepsisCare #ClinicalValidation #DigitalHealth #HealthcareInnovation #AIinMedicine #AisthesisMedical #StGeorge's

🚀 Exciting news from Aisthesis Medical! 🚀 We are thrilled to announce that Aisthesis Medical has been awarded funding from the MedTech Accelerator: Rapid Regulatory Support (MARRS) Programme by CPI UK! 🎉 This programme is a game-changer for #MedTech startups, providing tailored regulatory and market access support to accelerate the development and adoption of innovative medical technologies. For Aisthesis Medical, this means a faster and smoother path to regulatory approval for #VIOSync, our AI-driven sepsis care platform. With early detection, optimized clinical workflows, and reduced antibiotic overuse, #VIOSync is set to redefine how hospitals manage #sepsis and #AMR. ⚡ What this grant enables us to do: ✅ Strengthen regulatory strategies for CE MDR and FDA 510(k) approval ✅ Navigate market access challenges more efficiently ✅ Ensure compliance and scalability for widespread hospital adoption A huge thank you to CPI UK for supporting breakthrough #MedTech innovations like ours. We look forward to accelerating our journey to market and making a real impact in sepsis care worldwide! #MedTech #RegulatoryAffairs #AIinHealthcare #SepsisCare #Innovation #CPIUK #MARRSProgramme #AisthesisMedical

The Enterprise & Innovation Team at City St George’s, University of London is proud to host the Connect event. A showcase event for Industry seeking to engage with Knowledge Exchange (KE) Initiatives in the London region. Academics, Clinicians, Small & Medium Enterprises (SMEs) and Industrial Partners interested in engaging with both Enterprise & Innovation @ City St George’s, University of London and our London KE partners should consider registering to attend.   The following KE partners will be presenting and exhibiting at this event. Science & Engineering Health Technologies Alliance (SEHTA) Barclays Eagle Labs CityVentures Entrepreneurship programme Health Tech Enterprise Medtech Venture Builder programme Health Innovation Network South London Capital Enterprise Cancer Tech Accelerator   Join us on Thursday, 27th February 2025 (10 am – 3 pm) at City St George's, University of London (Tooting Campus). This event will also be hosted online for those who are unable to join us in person.   Please register here: https://lnkd.in/eFkn23KG Or using the QR code below

🚨 The Future of Patient Monitoring is Here 🚨 At Aisthesis Medical, we are transforming sepsis care with #VIOSync, our AI-driven sepsis care solution. A recent technical note in the Journal of Clinical Monitoring and Computing by Frederic Michard, MD, PhD 🚀 and Bernd Saugel reinforces what we’ve long believed—continuous, AI-powered monitoring is the key to early detection and improved outcomes. 🔍 Key Takeaways from the Study: ✅ Spot-checking isn’t enough—patients often show early warning signs of deterioration, but traditional monitoring misses up to 90% of these events. ✅ Continuous monitoring reduces risk—10+ major studies show that tracking vitals in real-time leads to fewer ICU admissions and lower mortality rates. ✅ Wearable, wireless sensors improve care—patients benefit from increased mobility and comfort, while clinicians receive timely alerts to intervene earlier. 💡 How This Reinforces Our Work at Aisthesis Medical: #VIOSync isn’t just another early warning system—it’s a comprehensive sepsis management solution that: 🔹 Predicts sepsis up to 48 hours in advance using AI-powered risk stratification. 🔹 Integrates seamlessly with EHRs, providing real-time insights where clinicians need them most. 🔹 Supports proactive intervention, not just passive alerts, improving adherence to sepsis care pathways. The evidence is clear—continuous, AI-driven monitoring is the future of patient care. At Aisthesis Medical, we are making that future a reality. #SepsisCare #AIinHealthcare #PatientMonitoring #MedicalInnovation #AisthesisMedical

🚨 The Future of Patient Monitoring is Here 🚨 At Aisthesis Medical, we are transforming sepsis care with #VIOSync, our AI-driven sepsis care solution. A recent technical note in the Journal of Clinical Monitoring and Computing by Frederic Michard, MD, PhD 🚀 and Bernd Saugel reinforces what we’ve long believed—continuous, AI-powered monitoring is the key to early detection and improved outcomes. 🔍 Key Takeaways from the Study: ✅ Spot-checking isn’t enough—patients often show early warning signs of deterioration, but traditional monitoring misses up to 90% of these events. ✅ Continuous monitoring reduces risk—10+ major studies show that tracking vitals in real-time leads to fewer ICU admissions and lower mortality rates. ✅ Wearable, wireless sensors improve care—patients benefit from increased mobility and comfort, while clinicians receive timely alerts to intervene earlier. 💡 How This Reinforces Our Work at Aisthesis Medical: #VIOSync isn’t just another early warning system—it’s a comprehensive sepsis management solution that: 🔹 Predicts sepsis up to 48 hours in advance using AI-powered risk stratification. 🔹 Integrates seamlessly with EHRs, providing real-time insights where clinicians need them most. 🔹 Supports proactive intervention, not just passive alerts, improving adherence to sepsis care pathways. The evidence is clear—continuous, AI-driven monitoring is the future of patient care. At Aisthesis Medical, we are making that future a reality. #SepsisCare #AIinHealthcare #PatientMonitoring #MedicalInnovation #AisthesisMedical

🌍🚀 Exciting News for Aisthesis Medical! 🚀🌍 We are thrilled to announce that Aisthesis Medical has been selected to present at the 1st edition of the Tech Tour AI for Health 2025, taking place in Bochum, Germany on 22-23 January! This prestigious event brings together industry leaders, innovators, and policymakers to discuss the future of AI in the Health sector. We are incredibly honoured to be part of this dynamic conversation and showcase our innovative solutions for a greener, cleaner future. Looking forward to sharing our journey and collaborating with other key players in the health sector! #TTAIforHealth #AisthesisMedical #TechTour #Innovation #Startup

🌟 Thrilled to announce that Aisthesis Medical has been selected as part of the UK delegation for the Innovate UK Antimicrobial Resistance (#AMR) Global Business Innovation Programme in Switzerland! 🇨🇭 Last week, we took part in the first preparation workshop, where we met an inspiring cohort of innovative companies and delved into the incredible work being done to tackle the global health challenge of #AMR. 🚀 We're excited to share how #VIOSync, our cutting-edge AI-driven solution, is redefining sepsis care and supporting the fight against #AMR through early detection, optimized treatment pathways, and reducing unnecessary antibiotic use. This program is an incredible opportunity to explore partnerships and collaborations in Switzerland and beyond. If you're attending the AMR Conference in Basel this February, let’s connect and exchange ideas to address this pressing global issue together! 🌍 💡 Stay tuned for more updates from our journey! #AMRGBIP #InnovateUK #AMRconference #HealthcareInnovation #AisthesisMedical #SepsisCare #AMR

🔎 Improving Patient Outcomes through Continuous Monitoring and AI Solutions A recent publication in the British Journal of Anaesthesia highlights the critical gaps in patient monitoring in general hospital wards. Despite technological advances, many postoperative deaths stem from undetected vital sign changes, with most monitoring still relying on intermittent, manual checks every 4–8 hours. This leaves significant periods where subtle but critical deterioration goes unnoticed. The study underscores the potential of continuous vital sign monitoring enabled by AI-driven solutions, which can detect early changes in patient physiology and prevent adverse events like ICU admissions or mortality. However, challenges such as alarm fatigue, connectivity, and cost remain barriers to widespread adoption. At Aisthesis Medical, we’ve taken significant strides to address these gaps. Our #VIOSync platform integrates with third-party medical-grade wearable devices to enable continuous monitoring in emergency rooms and general wards. Powered by explainable AI, #VIOSync not only provides real-time insights but also predicts sepsis and other complications up to 48 hours before clinical symptoms appear. Our focus is not just on capturing more data but ensuring that insights lead to timely, actionable interventions that can save lives and reduce the burden on healthcare systems across Europe and beyond. As hospitals across the EU grapple with these shared challenges, #VIOSync aims to lead the shift toward smarter, safer, and more efficient care. Let’s transform healthcare together! 📖 Read the full article here: https://lnkd.in/d9YMqsFn #VIOSync #DigitalHealth #HealthTech #PatientSafety #AIinMedicine #ContinuousMonitoring #SepsisManagement #Sepsis

🚨 Italy’s Health Data System: A Warning for the EU? A recent The Lancet Group Regional Health editorial highlights Italy's fragmented health data system, a stark example of how regional autonomy and outdated technologies can cripple healthcare efficiency. Patients face delays, costs soar (€3.3B annually for interregional care), and research stagnates due to poor data integration. This isn't just Italy’s problem—other EU countries with decentralized systems risk similar outcomes. Programs like the EDAH - European Data Space in Health and the Data Governance Act are steps in the right direction, but national governments must prioritize their implementation. A unified, interoperable approach will not only ensure equitable healthcare access but also foster innovative, data-driven solutions. Italy’s struggles show that a fractured system costs lives and progress. Can Europe learn from this? #Healthcare #PublicHealth #DataIntegration #EUInnovation #HealthcareInnovation #Europe #Interoperability #HealthPolicy Full-text: https://lnkd.in/dKDhiGfs

🎄 It’s Christmas Eve, and there’s no better time to reflect on the incredible journey we’ve had this year. This year has shown us that #teamwork truly makes the dream work. 💡🤝 Our recent #teambuilding trip to Kalavryta, Greece, wasn’t just a getaway—it was a celebration of collaboration, resilience, and shared goals. Ioannis Zorzos Pavlos Giakoumakis Agathi Kari Thank you for your passion, dedication, and resilience. Here’s to everything we’ve accomplished—and to even greater success in 2025. As we look ahead to 2025, we’re stronger, more connected, and ready to tackle new challenges—together. Wishing everyone in our LinkedIn family a #MerryChristmas and a joyous holiday season! May this time be filled with love, laughter, and inspiration. #Teamwork #Innovation #AIInHealthcare #StartupJourney #SepsisCare #DigitalHealth #Kalavryta #TeamBuilding #HolidaySeason #AisthesisMedical #CollaborationMatters